Introducing MindLight, the first SSRI antidepressant response test using brain-derived biomarkers. Read the press release to learn more.
Laura Ross
Chief Financial Officer
With 30 years of distinguished experience in both public and private sectors, Laura Ross is a dynamic and results-oriented Accounting and Finance professional. Her extensive career has been marked by a proven ability to develop and implement strategies that significantly enhance financial performance and optimize operational
metrics.
Prior to joining Circular Genomics, Laura excelled as a Fractional CFO for several early-stage bioscience and medical device companies. In these roles, she specialized in raising capital through public and private equity offerings, structured debt facilities, and licensing agreements. Her expertise in these areas has been instrumental in helping companies achieve their strategic objectives and scale their operations effectively.
Laura’s commitment to leveraging her deep industry knowledge and financial acumen is central to her role in supporting bioscience companies. She is dedicated to driving growth and achieving strategic goals within the industry.
Laura holds a Bachelor’s degree in accountancy from the University of San Diego and began her career with PriceWaterhouseCoopers and Ernst & Young. Her extensive background and commitment to excellence make her a valuable asset to the Circular Genomics team.